企業プロフィール
Emergent BioSolutions 株価・ニュース・カタリスト
- ティッカー:
- EBS
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.82 USD (-1.43%)
終値
最終更新: 2026年8月20日
424M USD
時価総額
株価変動の要因
As of Aug 20, 2026, EBS closed down 1.43% at $4.82. No new same-company headline was identified in the current news window.
企業概要
事業概要
Emergent BioSolutions is a biodefense and specialty products company focused on public-health preparedness, vaccines, and medical countermeasures. Its business is centered on government and specialty healthcare contracts.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Emergent sits in specialty healthcare and biodefense.
ビジネスモデルの特徴
The company depends on government contracts, product supply, and the execution of its public-health franchise.
バイオ業界での位置付け
Emergent is outside biotech proper and belongs to the biodefense and specialty-products layer.
今後のカタリスト
- Emergent BioSolutions’ catalysts are biodefense contract awards, manufacturing execution, and any update on its public-health products. The market will care about whether the company can keep its federal-defense and infectious-disease franchise stable.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。